125 related articles for article (PubMed ID: 26297398)
41. Cigarette smoking and antiplatelet effects of aspirin monotherapy versus clopidogrel monotherapy in patients with atherosclerotic disease: results of a prospective pharmacodynamic study.
Rollini F; Franchi F; Cho JR; Degroat C; Bhatti M; Ferrante E; Patel R; Darlington A; Tello-Montoliu A; Desai B; Ferreiro J; Muniz-Lozano A; Zenni MM; Guzman LA; Bass TA; Angiolillo DJ
J Cardiovasc Transl Res; 2014 Feb; 7(1):53-63. PubMed ID: 24395495
[TBL] [Abstract][Full Text] [Related]
42. Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients.
Paniccia R; Antonucci E; Maggini N; Miranda M; Gori AM; Marcucci R; Giusti B; Balzi D; Prisco D; Abbate R
Thromb Haemost; 2010 Aug; 104(2):287-92. PubMed ID: 20458439
[TBL] [Abstract][Full Text] [Related]
43. Comparison of a new P2Y12 receptor specific platelet aggregation test with other laboratory methods in stroke patients on clopidogrel monotherapy.
Bagoly Z; Sarkady F; Magyar T; Kappelmayer J; Pongrácz E; Csiba L; Muszbek L
PLoS One; 2013; 8(7):e69417. PubMed ID: 23844259
[TBL] [Abstract][Full Text] [Related]
44. Response variability to P2Y12 receptor inhibitors: expectations and reality.
Siller-Matula JM; Trenk D; Schrör K; Gawaz M; Kristensen SD; Storey RF; Huber K;
JACC Cardiovasc Interv; 2013 Nov; 6(11):1111-28. PubMed ID: 24262612
[TBL] [Abstract][Full Text] [Related]
45. Whole Blood Platelet Aggregation Test and Prediction of Hemostatic Difficulty After Tooth Extraction in Patients Receiving Antiplatelet Therapy.
Nagao Y; Masuda R; Ando A; Nonaka M; Nishimura A; Goto K; Maruoka Y; Iijima T
Clin Appl Thromb Hemost; 2018 Jan; 24(1):151-156. PubMed ID: 28511553
[TBL] [Abstract][Full Text] [Related]
46. The influencing factors for clopidogrel-mediated platelet inhibition are assay-dependent.
Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
Thromb Res; 2011 Oct; 128(4):352-7. PubMed ID: 21621250
[TBL] [Abstract][Full Text] [Related]
47. Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood.
Tóth O; Calatzis A; Penz S; Losonczy H; Siess W
Thromb Haemost; 2006 Dec; 96(6):781-8. PubMed ID: 17139373
[TBL] [Abstract][Full Text] [Related]
48. Assessment of the response to acetylsalicylic acid in patients with myeloproliferative neoplasms by whole blood assays: a comparison of the PFA-100 with multiple electrode aggregometry.
Robier C; Neubauer M; Quehenberger F; Stettin M; Neumeister P
Platelets; 2014; 25(8):608-11. PubMed ID: 24245548
[TBL] [Abstract][Full Text] [Related]
49. Genetic polymorphisms of platelet receptors in patients with acute myocardial infarction and resistance to antiplatelet therapy.
Ulehlova J; Slavik L; Kucerova J; Krcova V; Vaclavik J; Indrak K
Genet Test Mol Biomarkers; 2014 Sep; 18(9):599-604. PubMed ID: 25093390
[TBL] [Abstract][Full Text] [Related]
50. Bleeding risk assessment using multiple electrode aggregometry in patients following coronary artery bypass surgery.
Petricevic M; Biocina B; Milicic D; Konosic S; Ivancan V; Milosevic M; Burcar I; Gasparovic H
J Thromb Thrombolysis; 2013 Jan; 35(1):31-40. PubMed ID: 22926758
[TBL] [Abstract][Full Text] [Related]
51. Comparison of conventional aggregometry with VASP for monitoring P2Y12-specific platelet inhibition.
Aradi D; Magyarlaki T; Tokés-Füzesi M; Rideg O; Vorobcsuk A; Komócsi A
Platelets; 2010; 21(7):563-70. PubMed ID: 20642320
[TBL] [Abstract][Full Text] [Related]
52. G-protein-coupled receptors signaling pathways in new antiplatelet drug development.
Gurbel PA; Kuliopulos A; Tantry US
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):500-12. PubMed ID: 25633316
[TBL] [Abstract][Full Text] [Related]
53. Differential impact of cytochrome 2C9 allelic variants on clopidogrel-mediated platelet inhibition determined by five different platelet function tests.
Gremmel T; Kopp CW; Seidinger D; Koppensteiner R; Panzer S; Sunder-Plassmann R; Mannhalter C; Steiner S
Int J Cardiol; 2013 Jun; 166(1):126-31. PubMed ID: 22075408
[TBL] [Abstract][Full Text] [Related]
54. Impedance aggregometric analysis of platelet function of apheresis platelet concentrates as a function of storage time.
Glas M; Bauer JV; Eichler H; Volk T
Scand J Clin Lab Invest; 2016 Dec; 76(8):664-670. PubMed ID: 27701904
[TBL] [Abstract][Full Text] [Related]
55. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study.
Malinin A; Pokov A; Spergling M; Defranco A; Schwartz K; Schwartz D; Mahmud E; Atar D; Serebruany V
Thromb Res; 2007; 119(3):277-84. PubMed ID: 16563469
[TBL] [Abstract][Full Text] [Related]
56. Comparison of factors affecting platelet reactivity in various platelet function tests.
Choi SY; Kim MH
Platelets; 2019; 30(5):631-636. PubMed ID: 30059640
[TBL] [Abstract][Full Text] [Related]
57. The influence of drugs used in cardiac anaesthesia and critical care on multiple electrode aggregometry: an in-vitro volunteer study.
Morisoli AP; Gronchi F; Ferrari E; Blanc C; Frascarolo P; Angelillo-Scherrer A; Marcucci C
Eur J Anaesthesiol; 2014 Sep; 31(9):499-504. PubMed ID: 25010745
[TBL] [Abstract][Full Text] [Related]
58. Inhibitory Effects of P2Y12 Receptor Antagonist on PAR1- and PAR4-AP-Induced Platelet Aggregation in Patients with Stroke or TIA.
Kamada A; Shimizu M; Oura K; Yoshida M; Tsuda K; Oi K; Ishigaku Y; Natori T; Narumi S; Itabashi R; Maeda T; Terayama Y
J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105547. PubMed ID: 33360254
[TBL] [Abstract][Full Text] [Related]
59. Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registry.
Olivier CB; Diehl P; Schnabel K; Weik P; Zhou Q; Bode C; Moser M
Thromb Haemost; 2014 Feb; 111(2):266-72. PubMed ID: 24172891
[TBL] [Abstract][Full Text] [Related]
60. Sequential ADP-stimulated light transmission and multiple electrode aggregometry in patients taking aspirin and clopidogrel after non ST-elevation myocardial infarction.
Meen O; Brosstad F; Liestøl K; Kunszt G; Bendz B; Wettergreen M; Schjelderup NM; Andreassen T; Erikssen G
Scand J Clin Lab Invest; 2012 Jul; 72(4):318-25. PubMed ID: 22724626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
